Low dose resveratrol improves cerebrovascular function in type 2 diabetes mellitus

被引:74
|
作者
Wong, R. H. X. [1 ]
Nealon, R. S. [1 ]
Scholey, A. [2 ]
Howe, P. R. C. [1 ]
机构
[1] Univ Newcastle, Sch Biomed Sci & Pharm, Clin Nutr Res Ctr, Univ Dr,Med Sci Bldg,MS304, Callaghan, NSW 2308, Australia
[2] Swinburne Univ, Ctr Human Psychopharmacol, Hawthorn, Vic 3122, Australia
基金
英国医学研究理事会;
关键词
Cerebrovascular circulation; Diabetes mellitus; Nutrition; Vasodilatation; INSULIN-RESISTANCE; NITRIC-OXIDE; REACTIVITY; RESPONSIVENESS; FLOW;
D O I
10.1016/j.numecd.2016.03.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aims: Progressive microvascular dysfunction in type 2 diabetes mellitus (T2DM) may impair the ability of cerebral vessels to supply blood to brain regions during local metabolic demand, thereby increasing risks of dementia. Having previously demonstrated that resveratrol can enhance vasodilator function in the systemic circulation, we hypothesised that resveratrol could similarly benefit the cerebral circulation. We aimed to determine the most efficacious dose of resveratrol to improve cerebral vasodilator responsiveness (CVR) in T2DM. Methods and results: In a double-blind, placebo-controlled, balanced crossover intervention, 36 dementia-free, non-insulin dependent T2DM older adults (49-78 years old) consumed single doses of synthetic trans-resveratrol (0, 75, 150, and 300 mg) at weekly intervals. Transcranial Doppler ultrasound was used to assess CVR to a hypercapnic stimulus, both before and 45 min after treatment. CVR, measured bilaterally in the middle cerebral arteries (MCA) and posterior cerebral arteries (PCA), was expressed as the percentage change in mean blood flow velocity from baseline to the peak velocity attained during hypercapnia. Resveratrol consumption increased CVR in the MCA; mean within-individual changes for each dose from placebo were 13.8 +/- 3.5% for 75 mg (P = 0.001), 8.9 +/- 3.5% for 150 mg (P = 0.016), and 13.7 +/- 3.3% for 300 mg (P < 0.001); only the 75 mg dose was efficacious in the PCA (13.2 +/- 4.5%, P = 0.016). Conclusions: Our results provide the first clinical evidence of an acute enhancement of vasodilator responsiveness in cerebral vessels following consumption of resveratrol in this population who are known to have endothelial dysfunction and sub-clinical cognitive impairment. Importantly, maximum improvement was observed with the lowest dose used. (C) 2016 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:393 / 399
页数:7
相关论文
共 50 条
  • [41] Cognitive function in patients with type 2 diabetes mellitus
    Biessels, GJ
    ter Braak, EWMT
    Erkelens, DW
    Hijman, R
    NEUROSCIENCE RESEARCH COMMUNICATIONS, 2001, 28 (01) : 11 - 22
  • [42] Arginase Inhibition Improves Endothelial Function in Patients With Coronary Artery Disease and Type 2 Diabetes Mellitus
    Shemyakin, Alexey
    Koevamees, Oskar
    Rafnsson, Arnar
    Boehm, Felix
    Svenarud, Peter
    Settergren, Magnus
    Jung, Christian
    Pernow, John
    CIRCULATION, 2012, 126 (25) : 2943 - U268
  • [43] Cardiac Function in Uncomplicated Type 2 Diabetes Mellitus
    Agrawal, Bimal K.
    Jain, Parul
    Marwaha, Saurabh
    Goel, Richa
    Kumar, Himanshu D.
    Jagdish
    BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2019, 18 (02): : 211 - 215
  • [44] The characteristic of cognitive function in Type 2 diabetes mellitus
    Gao, Yuxia
    Xiao, Yanyu
    Miao, Rujuan
    Zhao, Jiangang
    Zhang, Wenwen
    Huang, Guowei
    Ma, Fei
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2015, 109 (02) : 299 - 305
  • [45] Low-Dose Atorvastatin Treatment Improves Arterial Stiffness in Patients with Type 2 Diabetes
    Grigoropoulou, Pinelopi
    Eleftheriadou, Ioanna
    Zoupas, Christos
    Kokkinos, Alexander
    Perrea, Despoina
    Makrilakis, Konstantinos
    Tentolouris, Nikolaos
    DIABETES, 2015, 64 : A177 - A177
  • [46] The Bilirubin-Increasing Drug Atazanavir Improves Endothelial Function in Patients With Type 2 Diabetes Mellitus
    Dekker, Douwe
    Dorresteijn, Mirrin J.
    Pijnenburg, Margot
    Heemskerk, Suzanne
    Rasing-Hoogveld, Anja
    Burger, David M.
    Wagener, Frank A. D. T. G.
    Smits, Paul
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (02) : 458 - 463
  • [47] Bardoxolone improves kidney function in type 2 diabetes
    Thomas, Merlin C.
    Cooper, Mark E.
    NATURE REVIEWS NEPHROLOGY, 2011, 7 (10) : 552 - 553
  • [48] Bardoxolone improves kidney function in type 2 diabetes
    Merlin C. Thomas
    Mark E. Cooper
    Nature Reviews Nephrology, 2011, 7 : 552 - 553
  • [49] Exercise improves endothelial function in type 2 diabetes
    De Filippis, EA
    Cusi, K
    Fernandez, M
    Mandarino, LJ
    DIABETES, 2004, 53 : A8 - A8
  • [50] Low-carbohydrate diet in type 2 diabetes mellitus; [Koolhydraatarme voeding bij diabetes mellitus type 2]
    van Hoek-Ottenkamp W.
    Huisarts en wetenschap, 2017, 60 (12) : 660 - 663